Every day companies announce news that can change the future of their business. Today we are featuring four companies that have recently announced news that could be important for their growth:
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) on January 4, 2023 announced the launch of “two new products expanding its line of office dispense products exclusively for dermatologists and medical spas”. As the company explained in the press release, “Sonoma is targeting its office distribution program to dermatology practices and medical spas. Clients will be able to purchase Sonoma’s prescription strength products directly from their skin care professional, instead of making a separate trip to the pharmacy.”
This is an exciting development considering that, as the company explains:
“All of Sonoma’s office dispense products are powered by Microcyn® technology, which is clinically-proven to accelerate healing, fight infection, and reduce itch, pain, redness and irritation that can result from cosmetic and medical procedures available from dermatologists and medical spas. Microcyn® products have no contra-indications and can be used with sunscreens and lotions as well as prescription products such as steroids, making them an easy and effective addition to any skin care regime.”
Here are some of the company’s comments from this press release:
“”We are excited to expand our line of products available to clients through dermatologists and medical spas. The market for aesthetic procedures is growing, and in-office dispensing is becoming more popular as physicians recognize the benefits for both their practice and their clients. By making our products available at the time of their visit, clients will have a better experience at their dermatologist or medical spa, save money and time, and they can begin using the product immediately after the treatment to reduce redness, itch and pain while accelerating healing,” said Amy Trombly, CEO of Sonoma Pharmaceuticals.”
SNOA is “a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including dermatology, eye, oral and nasal care, and wound care”.
Cosmos Health Inc. (NASDAQ: COSM) on January 17, 2023 provided an “update on its debt balance and proforma interest expense”. As the company explained in this press release it “Reduced its debt by 78% from $21.2M in 2021 to $4.6M in 2022 and expects interest expense in 2023 to be $0.6M versus $2.2M in 2022.” COSM is “a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals”.
Furthermore, as the company explained in this press release:
“Greg Siokas, Chief Executive Officer of Cosmos Health stated, “We are happy to have achieved our goal of strengthening our balance sheet, by substantially reducing our debt. Our new capital structure not only decreases our risk profile, but also lowers our interest expense. Furthermore, our recently strengthened balance sheet allows us the ability to execute on our multi layered growth strategy which is now underway. We continue to enter into strategic agreements with partners which we expect to lead to revenue growth for many years to come.””
Astronics Corporation (NASDAQ: ATRO) on January 19, 2023 announced “Preliminary Sales for Fourth Quarter 2022 of $155 Million to $160 Million; Completes $205 Million Debt Refinancing”. ATRO “serves the world’s aerospace, defense, and other mission critical industries with proven, innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors, and test technologies to solve complex challenges”.
Here are some of the company’s comments from this press release:
“Peter J. Gundermann, Chairman, President and CEO, commented, “We continued to see strong order flow in the fourth quarter, as we have since the middle of 2021. We expect to report another positive book-to-bill quarter and another record ending backlog. More importantly, however, we finally saw the beginning of the sales ramp required to satisfy high demand as our supply chain continues to show improvement. We expect the sales ramp to endure as we move into 2023, consistent with our earlier revenue guidance for the year of $640 million to $680 million.””
Ally Financial Inc. (NYSE: ALLY) on January 20, 2023 announced “fourth quarter and full year 2022 financial results”. ALLY “is a financial services company with the nation’s largest all-digital bank and an industry-leading auto financing business, driven by a mission to “Do It Right” and be a relentless ally for customers and communities”. The company “serves more than 10.5 million customers through a full range of online banking services (including deposits, mortgage, point-of-sale personal lending and credit card products) and securities brokerage and investment advisory services”.
AwesomeStocks.com is an exclusive NASDAQ & NYSE stock alert service helping investors discover new companies with breaking news that have increased growth potential. AwesomeStocks.com provides a free newsletter featuring companies with expansion opportunities and growth to new markets as well as those undergoing mergers & acquisitions, obtaining new patents, and launching new products and partnerships. For more information or to subscribe to our free newsletter please visit AwesomeStocks.com.
AwesomeStocks.com (the “Publisher”) is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. Owners and operators of the Publisher have not been compensated nor expect to receive any compensation for the distribution of information discussed in this publication dated 1/23/23. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in this publication. This publication is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete. We have not determined if the information is accurate, correct or truthful.
The publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. For our full Disclaimer please visit: https://awesomestocks.com/disclaimer/